日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Illustrating an Adaptive Prespecification Framework for Observational Research: Target Trial Emulations Comparing Immunomodulator Treatments for COVID-19

展示一种用于观察性研究的自适应预定义框架：以COVID-19免疫调节剂治疗的靶向试验模拟为例

期刊:Epidemiology
影响因子:4.4
doi:10.1097/EDE.0000000000001901
Weckstein, Andrew R; Frajzyngier, Vera; Vititoe, Sarah E; Baglivo, Aidan; Beebe, Elisha; Govil, Priya; Bradley, Marie C; Perez-Vilar, Silvia; Liu, Wei; Rivera, Donna R; Lasky, Tamar; Chakravarty, Aloka; Garry, Elizabeth M; Gatto, Nicolle M
免疫/内分泌
发表日期：2025
文献求助 收藏

Increasing the Utility of Real-World Data to Inform Public Health Decision Making Through a US-based Private-Public Partnership: 10 Lessons Learned from a Principled Approach to Rapid Pandemic RWE Generation

通过美国公私合作项目提升真实世界数据在公共卫生决策中的应用价值：从快速生成疫情真实世界证据的原则性方法中汲取的10条经验教训

期刊:
影响因子:
doi:10.1007/s43441-025-00748-4
Gatto, Nicolle M; Garry, Elizabeth M; Wang, Melanie; Zariffa, Névine; Roe, Laura; Chakravarty, Aloka; Rivera, Donna
发表日期：2025
文献求助 收藏

Effectiveness and Safety of the MVA-BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc)

美国高危人群中 MVA-BN 疫苗预防痘苗的有效性和安全性 (USMVAc)

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines12060651
Back, Soowoo; Knox, Bethany; Coakley, Ciara; Deltour, Nicolas; Jacquot, Emmanuelle; Raad, Hanaya; Garry, Elizabeth M
发表日期：2024
文献求助 收藏

Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials.

利用非随机数据库分析模拟随机临床试验：32 项临床试验的结果

期刊:Journal of the American Medical Association
影响因子:55
doi:10.1001/jama.2023.4221
Wang Shirley V, Schneeweiss Sebastian, Franklin Jessica M, Desai Rishi J, Feldman William, Garry Elizabeth M, Glynn Robert J, Lin Kueiyu Joshua, Paik Julie, Patorno Elisabetta, Suissa Samy, D'Andrea Elvira, Jawaid Dureshahwar, Lee Hemin, Pawar Ajinkya, Sreedhara Sushama Kattinakere, Tesfaye Helen, Bessette Lily G, Zabotka Luke, Lee Su Been, Gautam Nileesa, York Cassie, Zakoul Heidi, Concato John, Martin David, Paraoan Dianne, Quinto Kenneth
发表日期：2023
文献求助 收藏

The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License Applications

真实世界证据在FDA批准的新药和生物制品许可申请中的作用

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.2474
Purpura, Christina A; Garry, Elizabeth M; Honig, Nicholaas; Case, Abigail; Rassen, Jeremy A
发表日期：2022
文献求助 收藏

Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis

慢性纤维化间质性肺疾病进展型患者的医疗资源利用及相关成本：一项基于美国医疗保险索赔数据库的分析

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-022-02066-9
Olson, Amy L; Hartmann, Nadine; Patnaik, Padmaja; Garry, Elizabeth M; Bohn, Rhonda L; Singer, David; Baldwin, Michael; Wallace, Laura
发表日期：2022
文献求助 收藏

Treatment Transitions in Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases

慢性阻塞性肺疾病治疗方案的转变：美国和英国医疗保健数据库的回顾性分析

期刊:Pulmonary Therapy
影响因子:3
doi:10.1007/s41030-021-00180-7
Bloom, Chloe I; Montonen, Jukka; Jöns, Olaf; Garry, Elizabeth M; Bhatt, Surya P
慢性阻塞性肺疾病
发表日期：2022
文献求助 收藏

First Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases

慢性阻塞性肺疾病的一线维持治疗：美国和英国医疗保健数据库的回顾性分析

期刊:Pulmonary Therapy
影响因子:3
doi:10.1007/s41030-021-00179-0
Bloom, Chloe I; Montonen, Jukka; Jöns, Olaf; Garry, Elizabeth M; Bhatt, Surya P
慢性阻塞性肺疾病
发表日期：2022
文献求助 收藏

Describing characteristics and treatment patterns of patients hospitalized with COVID-19 by race and ethnicity in a national RWD during the early months of the pandemic

在疫情初期，利用全国真实世界数据，按种族和族裔描述新冠肺炎住院患者的特征和治疗模式

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0267815
Vititoe, Sarah E; Easthausen, Imaani J; Lasky, Tamar; Chakravarty, Aloka; Bradley, Marie C; Roe, Laura M; Gatto, Nicolle M; Weckstein, Andrew R; Garry, Elizabeth M
肺炎
新冠
微生物学
发表日期：2022
文献求助 收藏

Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score-matched cohort analysis

在日本慢性阻塞性肺疾病（COPD）患者中，早期使用固定剂量噻托溴铵/奥达特罗与单独使用噻托溴铵进行干预的真实世界疗效比较：一项高维倾向评分匹配队列分析

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-021-01776-y
Muro, Shigeo; Suzuki, Masaru; Nakamura, Shuhei; Wang, Jocelyn Ruoyi; Garry, Elizabeth M; Sakamoto, Wataru; de Souza, Sabrina
COPD
慢性阻塞性肺疾病
发表日期：2021
文献求助 收藏